AHK-Cu and CJC-1295 with DAC Interaction

Synergistic
Mechanism-based 47% confidence

AHK-Cu and CJC-1295 with DAC have a synergistic interaction with 47% confidence. AHK-Cu and CJC-1295 with DAC work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

AHK-Cu

Hair Growth Copper Peptide | Dermal Papilla Stimulator

AHK-Cu penetrates scalp delivering copper directly to dermal papilla cells. Activates proliferation pathways, elevates Bcl-2/Bax ratio (anti-apoptotic), increases VEGF for blood flow, reduces TGF-β1, and promotes SOD production for oxidative stress reduction.

Half-life: Not established Typical dose: 0.5-1% topical solution/serum skin, healing
tgf betavegf
View full profile

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

Combined Organ Load

Blood Vessels
low
Skin
low
GI Tract
low
Pituitary
low

Frequently Asked Questions

Can I take AHK-Cu with CJC-1295 with DAC?

Yes, AHK-Cu and CJC-1295 with DAC can generally be taken together. AHK-Cu and CJC-1295 with DAC work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is AHK-Cu and CJC-1295 with DAC safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between AHK-Cu and CJC-1295 with DAC?

AHK-Cu and CJC-1295 with DAC work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time AHK-Cu and CJC-1295 with DAC?

AHK-Cu has a half-life of Not established and CJC-1295 with DAC has a half-life of 6-8 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: AHK-Cu vs CJC-1295 with DAC

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.